Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 6784607, 9 pages
https://doi.org/10.1155/2018/6784607
Review Article

Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression

Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China

Correspondence should be addressed to Tianshu Liu; moc.361@99uhsnait_uil

Received 8 December 2017; Accepted 8 February 2018; Published 22 May 2018

Academic Editor: Xin-yuan Guan

Copyright © 2018 Erbao Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, and J. Lortet-Tieulent, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar
  2. N. Akamatsu, U. Cillo, A. Cucchetti et al., “Surgery and hepatocellular Carcinoma,” Liver Cancer, vol. 6, no. 1, pp. 44–50, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Schlesinger, K. Aleksandrova, T. Pischon et al., “Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European Cohort,” Annals of Oncology, vol. 24, no. 9, pp. 2449–2455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-H. Chiang, L.-T. Lee, S.-H. Hung et al., “Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly,” Hepatology, vol. 59, no. 6, pp. 2207–2215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Hassan, R. Abdel-Wahab, A. Kaseb et al., “Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma,” Gastroenterology, vol. 149, no. 1, Article ID 59705, pp. 119–129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Fang, Y. Feng, T. Wu et al., “Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a,” PLoS ONE, vol. 8, no. 8, p. e73004, 2013. View at Publisher · View at Google Scholar
  7. K. Okuda, “Hepatocellular carcinoma,” Journal of Hepatology, vol. 32, no. 1, pp. 225–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tanaka, K. Miyanishi, M. Kobune et al., “Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma,” Journal of Gastroenterology, vol. 48, no. 11, pp. 1249–1258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. W.-H. Ho, R. C.-L. Lo, L.-K. Chan, and I. O.-L. Ng, “Molecular Pathogenesis of Hepatocellular Carcinoma,” Liver Cancer, vol. 5, no. 4, pp. 290–302, 2016. View at Publisher · View at Google Scholar
  10. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Guo, N. T. Ingolia, J. S. Weissman, and D. P. Bartel, “Mammalian microRNAs predominantly act to decrease target mRNA levels,” Nature, vol. 466, no. 7308, pp. 835–840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. M. Borchert, W. Lanier, and B. L. Davidson, “RNA polymerase III transcribes human microRNAs,” Nature Structural & Molecular Biology, vol. 13, no. 12, pp. 1097–1101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Stewart, “Nuclear Export of Small RNAs,” Science, vol. 326, no. 5957, pp. 1195-1196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hou, L. Lin, W. Zhou et al., “Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma,” Cancer Cell, vol. 19, no. 2, pp. 232–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Wang, J. Yao, H. Sun et al., “miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells,” Tumor Biology, vol. 37, no. 1, pp. 847–855, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Wang, J. Yao, X. Shi et al., “MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells,” BMC Cancer, vol. 13, article no. 448, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G.-G. Wu, W.-H. Li, W.-G. He et al., “Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma,” PLoS ONE, vol. 9, no. 2, Article ID e88796, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Petrelli, A. Perra, D. Cora et al., “MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC),” Hepatology, vol. 59, no. 1, pp. 228–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Zhang, X. Guo, Z. Li et al., “A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma,” RNA Biology, vol. 12, no. 6, pp. 643–657, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. K. Kim, J. H. Noh, K. H. Jung et al., “Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b,” Hepatology, vol. 57, no. 3, pp. 1055–1067, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Ngo-Yin Fan, F. Ho-Ching Tsang, A. Hoi-Kam Tam et al., “Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b,” Hepatology, vol. 57, no. 2, pp. 637–647, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Yang, F. Fang, R. Chang, and L. Yang, “MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma,” Hepatology, vol. 58, no. 1, pp. 205–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Furuta, K. Kozaki, K. Tanimoto et al., “The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma,” PLoS ONE, vol. 8, no. 3, Article ID e60155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-P. Li, X.-C. Zeng, B. Zhang et al., “miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct Suppression of IKK-β,” Carcinogenesis, vol. 34, no. 11, pp. 2443–2451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R.-F. Liu, X. Xu, J. Huang et al., “Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2,” Cancer Letters, vol. 329, no. 2, pp. 164–173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Y. Liu, C. F. Diao, and Y. Zhang, “MiR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells,” Cancer Letters, vol. 335, no. 2, pp. 351–360, 2013. View at Publisher · View at Google Scholar
  28. M. Rong, G. Chen, and Y. Dang, “Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro,” BMC Cancer, vol. 13, no. 1, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Giovannini, M. Minguzzi, M. Baglioni et al., “Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma,” Oncotarget , vol. 5, no. 21, pp. 10607–10620, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. X.-W. Yang, G.-Z. Shen, L.-Q. Cao et al., “MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1,” BMC Cancer, vol. 14, no. 1, article no. 909, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Yuan, Z. Lian, B. Sun, M. M. Clayton, I. O. L. Ng, and M. A. Feitelson, “Role of mir-148a in hepatitis B associated hepatocellular carcinoma,” PLoS ONE, vol. 7, no. 4, Article ID e35331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, J. Dai, H. Deng et al., “miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop,” British Journal of Cancer, vol. 112, no. 2, pp. 365–374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Wang, L.-J. Zhao, Y.-X. Tan, H. Ren, and Z.-X. Qi, “MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma,” Carcinogenesis, vol. 33, no. 5, pp. 1113–1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Lin, H. Liang, Y. Wang et al., “MicroRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells,” BMC Cancer, vol. 14, no. 1, article no. 879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Ma, X.-G. She, Y.-Z. Ming, and Q.-Q. Wan, “miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7,” Tumor Biology, vol. 35, no. 11, pp. 10731–10736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Zhang, K. Liu, S. Liu, B. Ji, Y. Wang, and Y. Liu, “MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma,” Tumor Biology, vol. 36, no. 12, pp. 9779–9788, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Liu, Y. Hei, Q. Shu et al., “VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma,” PLoS ONE, vol. 7, no. 4, Article ID e35800, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. M. Yang, C. G. Lee, J. H. Koo et al., “Galpha12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4a inactivation, which causes c-Met induction,” Oncotarget, vol. 6, no. 22, pp. 19055–19069, 2015. View at Google Scholar · View at Scopus
  39. R. Nassirpour, P. P. Mehta, and M.-J. Yin, “miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3,” PLoS ONE, vol. 8, no. 11, Article ID e79655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Ohta, H. Hoshino, J. Wang et al., “MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A,” Oncotarget , vol. 6, no. 5, pp. 3211–3224, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Shen, X. Rong, J. Zhao et al., “MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma,” Carcinogenesis, vol. 35, no. 12, pp. 2748–2755, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Gong, J.-P. Zhang, B. Li et al., “MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R,” Oncogene, vol. 32, no. 25, pp. 3071–3079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Cao, J. Sun, D. Zhang et al., “The long intergenic noncoding RNA UFC1, a target of microRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells,” Gastroenterology, vol. 148, no. 2, pp. 415–426.e18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Chen, H. Guan, C. Gu, Y. Cao, J. Shao, and F. Wang, “miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL,” Tumor Biology, vol. 37, no. 2, pp. 2497–2507, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Gramantieri, F. Fornari, M. Ferracin et al., “MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality,” Clinical Cancer Research, vol. 15, no. 16, pp. 5073–5081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Xue, Y. Zhang, Q. Zhi et al., “MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma,” Cell Communication and Signaling, vol. 12, no. 1, article no. 62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Liu, B. Ruan, N. You et al., “Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells,” PLoS ONE, vol. 8, no. 11, Article ID e79409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Zhang, S. Takahashi, A. Tasaka, T. Yoshima, H. Ochi, and K. Chayama, “Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 565–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. W.-C. Tsai, S.-D. Hsu, C.-S. Hsu et al., “MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis,” The Journal of Clinical Investigation, vol. 122, no. 8, pp. 2884–2897, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Dang, D. Luo, M. Rong, and G. Chen, “Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET,” PLoS ONE, vol. 8, no. 4, Article ID e61054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Zhou, W. Li, J. Guo, G. Li, F. Chen, and J. Zhou, “Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma,” Tumor Biology, vol. 37, no. 3, pp. 3561–3569, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Ni, H. Zhao, H. Cui et al., “MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma,” Cancer Letters, vol. 356, no. 2, pp. 809–818, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Xia, L. L. P. J. Ooi, and K. M. Hui, “MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer,” Hepatology, vol. 58, no. 2, pp. 629–641, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Tang, G. Tan, X. Jiang et al., “An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells,” Oncotarget , vol. 7, no. 45, pp. 73257–73269, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. H. J. Bae, K. H. Jung, J. W. Eun et al., “MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer,” Journal of Hepatology, vol. 63, no. 2, pp. 408–419, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Zhang, L. Yang, X. Liu et al., “MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways,” Hepatology, vol. 57, no. 5, pp. 1919–1930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Ding, S. Huang, Y. Wang et al., “Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma,” Hepatology, vol. 58, no. 2, pp. 654–666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. R.-M. Chang, H. Yang, F. Fang, J.-F. Xu, and L.-Y. Yang, “MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase,” Hepatology, vol. 60, no. 4, pp. 1251–1263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Fang, J.-L. Xue, Q. Shen, J. Chen, and L. Tian, “MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma,” Hepatology, vol. 55, no. 6, pp. 1852–1862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. B.-F. Ning, J. Ding, J. Liu et al., “Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression,” Hepatology, vol. 60, no. 5, pp. 1607–1619, 2014. View at Publisher · View at Google Scholar
  61. T.-C. Shih, Y.-J. Tien, C.-J. Wen et al., “MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma,” Journal of Hepatology, vol. 57, no. 3, pp. 584–591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Alpini, S. S. Glaser, J.-P. Zhang et al., “Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer,” Journal of Hepatology, vol. 55, no. 6, pp. 1339–1345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. J.-H. Fang, H.-C. Zhou, C. Zeng et al., “MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression,” Hepatology, vol. 54, no. 5, pp. 1729–1740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Bao, Y. Yan, C. Xu et al., “MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways,” Cancer Letters, vol. 337, no. 2, pp. 226–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. Z.-T. Chai, J. Kong, X. Zhu et al., “MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma,” PLoS ONE, vol. 8, no. 10, Article ID e77957, 2013. View at Publisher · View at Google Scholar
  66. R. Wang, N. Zhao, S. Li et al., “MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42,” Hepatology, vol. 58, no. 2, pp. 642–653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Zhou, R. Ma, W. Si et al., “MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth,” Cancer Letters, vol. 333, no. 2, pp. 159–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Zhu, Q. Pan, X. Zhang et al., “MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression,” Carcinogenesis, vol. 34, no. 9, pp. 2071–2079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Du, Z. Lv, L. Cao et al., “MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2,” Journal of Translational Medicine, vol. 12, article 259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. X. Yang, X. F. Zhang, and X. Lu, “MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway,” Hepatology, vol. 59, no. 5, pp. 1874–1885, 2014. View at Publisher · View at Google Scholar
  71. K. Zhu, Q. Pan, L.-Q. Jia et al., “MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells,” Scientific Reports, vol. 4, article 5524, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. J.-J. Yan, Y.-N. Zhang, J.-Z. Liao et al., “MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1,” Oncotarget , vol. 6, no. 30, pp. 29527–29542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Xu, S. Beckebaum, S. Iacob et al., “MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity,” Journal of Hepatology, vol. 60, no. 3, pp. 590–598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Han, D. Sun, W. Li et al., “A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis,” Hepatology, vol. 57, no. 6, pp. 2378–2389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. C. C.-L. Wong, C. Wong, E. K. Tung et al., “The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating rho-kinase 2,” Gastroenterology, vol. 140, no. 1, pp. 322–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Fang, R.-M. Chang, L. Yu et al., “MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma,” Journal of Hepatology, vol. 63, no. 4, pp. 874–885, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. X. He, Y. Chang, F. Meng et al., “MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo,” Oncogene, vol. 31, no. 28, pp. 3357–3369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. A. M. Liu, Z. Xu, F. H. Shek et al., “MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma,” PLoS ONE, vol. 9, no. 1, Article ID e86872, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Mano, S. Aishima, N. Fujita et al., “Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma,” Pathobiology, vol. 80, no. 3, pp. 146–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. S.-H. Lan, S.-Y. Wu, R. Zuchini et al., “Autophagy-preferential degradation of MIR224 participates in hepatocellular carcinoma tumorigenesis,” Autophagy, vol. 10, no. 9, pp. 1687–1689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. S.-H. Lan, S.-Y. Wu, R. Zuchini et al., “Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224,” Hepatology, vol. 59, no. 2, pp. 505–517, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Yang, Q.-J. Li, Y. Feng et al., “TGF-β-miR-34a-CCL22 signaling-induced treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma,” Cancer Cell, vol. 22, no. 3, pp. 291–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Yan, X. Dong, X. Zhong et al., “Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma,” Molecular Carcinogenesis, vol. 53, no. 12, pp. 960–969, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Esteller, “Non-coding RNAs in human disease,” Nature Reviews Genetics, vol. 12, no. 12, pp. 861–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. P. T.-Y. Law, A. K.-K. Ching, A. W.-H. Chan et al., “MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma,” Carcinogenesis, vol. 33, no. 6, pp. 1134–1141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Lim, A. Balakrishnan, N. Huskey et al., “MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer,” Hepatology, vol. 59, no. 1, pp. 202–215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. F.-Y. Huang, D. K.-H. Wong, W.-K. Seto, C.-L. Lai, and M.-F. Yuen, “Estradiol induces apoptosis via activation of miRNA-23a and p53: Implication for gender difference in liver cancer development,” Oncotarget , vol. 6, no. 33, pp. 34941–34952, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Wu, Q. Wang, J. Yao, H. Jiang, C. Xiao, and F. Wu, “MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptoticprotein B-cell lymphoma-extra large,” Oncology Letters, vol. 9, no. 1, pp. 213–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Cao, H. Li, Y. Hu, D. Ma, and X. Cai, “miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3,” Tumor Biology, vol. 35, no. 11, pp. 10759–10764, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Yuan, Q. Zhi, H. Zhao et al., “Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma,” Tumor Biology, vol. 36, no. 4, pp. 3093–3100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. J.-N. Zhou, Q. Zeng, and H.-Y. Wang, “MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4,” Hepatology, vol. 62, no. 3, pp. 801–815, 2015. View at Publisher · View at Google Scholar
  92. J.-Y. Huang, K. Zhang, D.-Q. Chen et al., “MicroRNA-451: Epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma,” Oncotarget , vol. 6, no. 21, pp. 18613–18630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Kogure, W. L. Lin, I. K. Yan, C. Braconi, and T. Patel, “Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth,” Hepatology, vol. 54, no. 4, pp. 1237–1248, 2011. View at Publisher · View at Google Scholar · View at Scopus